Racial/Ethnic differences in receipt of timely adjuvant therapy for older women with breast cancer: are delays influenced by the hospitals where patients obtain surgical care?
- PMID: 23663229
- PMCID: PMC3796107
- DOI: 10.1111/1475-6773.12063
Racial/Ethnic differences in receipt of timely adjuvant therapy for older women with breast cancer: are delays influenced by the hospitals where patients obtain surgical care?
Abstract
Objective: To examine whether hospitals where patients obtain care explain racial/ethnic differences in treatment delay.
Data source: Surveillance, Epidemiology, and End Results data linked with Medicare claims.
Study design: We examined delays in adjuvant chemotherapy or radiation for women diagnosed with stage I-III breast cancer during 1992-2007. We used multivariable logistic regression to assess the probability of delay by race/ethnicity and included hospital fixed effects to assess whether hospitals explained disparities.
Principal findings: Among 54,592 women, black (11.9 percent) and Hispanic (9.9 percent) women had more delays than whites (7.8 percent, p < .0001). After adjustment, black (vs. white) women had higher odds of delay (odds ratio = 1.25, 95 percent confidence interval = 1.10-1.42), attenuated somewhat by including hospital fixed effects (OR = 1.17, 95 percent CI = 1.02-1.33).
Conclusions: Hospitals are the important contributors to racial disparities in treatment delay.
Keywords: Breast cancer; delays; disparities.
© Health Research and Educational Trust.
Similar articles
-
Socioeconomic disparities in breast cancer treatment among older women.J Womens Health (Larchmt). 2014 Apr;23(4):335-41. doi: 10.1089/jwh.2013.4460. Epub 2013 Dec 19. J Womens Health (Larchmt). 2014. PMID: 24350590 Free PMC article.
-
Delays in breast cancer diagnosis and treatment by racial/ethnic group.Arch Intern Med. 2006 Nov 13;166(20):2244-52. doi: 10.1001/archinte.166.20.2244. Arch Intern Med. 2006. PMID: 17101943
-
Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?Med Care. 2009 Jul;47(7):765-73. doi: 10.1097/MLR.0b013e31819e1fe7. Med Care. 2009. PMID: 19536008
-
Racial disparities in the development of breast cancer metastases among older women: a multilevel study.Cancer. 2009 Feb 15;115(4):731-40. doi: 10.1002/cncr.24087. Cancer. 2009. PMID: 19130463 Free PMC article.
-
Residual treatment disparities after oncology referral for rectal cancer.J Natl Cancer Inst. 2008 May 21;100(10):738-44. doi: 10.1093/jnci/djn145. Epub 2008 May 13. J Natl Cancer Inst. 2008. PMID: 18477800 Free PMC article.
Cited by
-
Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.JAMA Oncol. 2016 Sep 1;2(9):1170-6. doi: 10.1001/jamaoncol.2016.0685. JAMA Oncol. 2016. PMID: 27243607 Free PMC article.
-
Disparities in breast cancer care and research: report from a Breast Cancer Research Foundation sponsored workshop, 9-10 October 2014.NPJ Breast Cancer. 2015 Oct 14;1:15013. doi: 10.1038/npjbcancer.2015.13. eCollection 2015. NPJ Breast Cancer. 2015. PMID: 28721369 Free PMC article. Review.
-
Racial disparities in diabetes care among incident breast, prostate, and colorectal cancer survivors: a SEER Medicare study.J Cancer Surviv. 2022 Feb;16(1):52-60. doi: 10.1007/s11764-021-01003-z. Epub 2021 Mar 4. J Cancer Surviv. 2022. PMID: 33661509 Free PMC article.
-
Improving the Clinical Treatment of Vulnerable Populations in Radiation Oncology.Adv Radiat Oncol. 2020 Aug 6;5(6):1093-1098. doi: 10.1016/j.adro.2020.07.018. eCollection 2020 Nov-Dec. Adv Radiat Oncol. 2020. PMID: 33305069 Free PMC article.
-
Racial Disparities in Breast Cancer Treatments and Adverse Events in the SEER-Medicare Data.Cancers (Basel). 2023 Aug 30;15(17):4333. doi: 10.3390/cancers15174333. Cancers (Basel). 2023. PMID: 37686609 Free PMC article.
References
-
- Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, Mendez J, Guth AA. “Missed Opportunities: Racial Disparities in Adjuvant Breast Cancer Treatment”. Journal of Clinical Oncology. 2006;24(9):1357–62. - PubMed
-
- Buist DS, Chubak J, Prout M, Yood MU, Bosco JL, Thwin SS, Gold HT, Owusu C, Field TS, Quinn VP, Wei F, Silliman RA. “Referral, Receipt, and Completion of Chemotherapy in Patients with Early-Stage Breast Cancer Older Than 65 Years and at High Risk of Breast Cancer Recurrence”. Journal of Clinical Oncology. 2009;27(27):4508–14. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical